Immunex Message Board - Msg: 9495270

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roger Cranwill who wrote (321)	5/12/1999 3:45:00 PM
From: DJ	Read Replies (1) of 656

Roger, I think this is a classic case of a biotech company that has been R&Ding for years (since 1981) and finally is seeing products come to market. Not atypical in this industry where 10+ years may be needed for product development, even in well-managed companies with top scientists. The interesting question is: since IMNX stock limped along for so long before Enbrel was announced last year, what are the other winning biotechs out there that are in a similar position that IMNX was in in 1998--about to take off. Any insights out there?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next